Following the procedure, the patient no longer requires ureteric stents and has normal urine flow from the kidneys to the bladder.

The firm is focused on helping pharma characterize response and resistance to their drugs, with the hope of getting a companion diagnostic approval.

Prostate cancer causes around 12,000 deaths each year but the available tests are unreliable according to experts ...

Decision making is evidence based and must be shielded from lobbying The NHS draft recommendation against routine prostate ...

Thousands of women with a cancer-causing genetic mutation are facing an agonising wait for a mastectomy, due to a backlog ...

Scientists at the University of Cambridge are developing a blood test that could transform how prostate cancer is detected in ...

A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely ...

A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely ...

“For localised prostate cancer, treatment options include surgery or radiotherapy. Both give equivalent cure rates,” Dr Komen ...

The UK National Screening Committee’s recent recommendation to introduce prostate cancer screening for men with faulty BRCA ...

The Urology Care Foundation and the Prostate Cancer Foundation have created a new educational guide on genetic tests to guide ...